Company: SRPT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-269436
Chunk: 5

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 2
Chunk 5
---
None

Item 3. Defaults Upon Senior Securities. 

None. 

Item 4. Mine Safety Disclosures. 

None. 

Item 5. Other Information. 

During the three months ended September 30, 2025, the Michael A. Chambers Living Trust, an affiliate of Michael Chambers, entered into and adopted a written plan for the sale of our securities that is intended to satisfy the conditions specified in Rule 10b5-1(c) under the Exchange Act for an affirmative defense against liability for trading in securities on the basis of material nonpublic information (a “Rule 10b5-1 trading plan”). Mr. Chambers' 10b5-1 trading plan has an adoption date of September 16, 2025 and an end date of October 31, 2026, covering 88,286 shares of common stock. As of the date of issuance of this Quarterly Report, Mr. Chambers beneficially owns 294,694 shares of common stock, inclusive of the shares of common stock underlying the plan.

Item 6. Exhibits. 

The exhibits listed on the Exhibit Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q. 

EXHIBIT INDEX

     Incorporated by Reference toFilings Indicated

     ExhibitNumber
      
     Exhibit Description
      
     Form
      
     FileNo.
      
     Exhibit
      
     FilingDate
      
     ProvidedHerewith

        3.1
      
     Amended and Restated Certificate of Incorporation.
      
     8-K12B
      
     001-14895
      
     3.1
      
     6/6/13

        3.2
      
     Amendment to the Amended and Restated Certificate of Incorporation.
      
     8-K
      
     001-14895
      
     3.1
      
     6/30/15

        3.3
      
     Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sarepta Therapeutics, Inc.
      
     8-K
      
     001-14895
      
     3.1
      
     6/8/20

        3.4
      
     Second Amended and Restated Bylaws